Cafepharma Today

September 19 2024 - Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says
Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says
Havas Lynx explores pharma marketers’ role in addressing climate health crisis
Roche reports positive data from Phase III influenza treatment trial
ICER mulls GSK COPD drugs ahead of next Medicare negotiation
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Cerimon reports positive results from Phase II study of topical pain patch
Pharmaceutical Business Review
Saturday, September 13, 2008 - 12:43pm
tags:
Cyclacel expands Phase II sapacitabine trial to include MDS patients
Pharmaceutical Business Review
Saturday, September 13, 2008 - 12:42pm
tags:
Calando Pharmaceuticals initiates Phase II ovarian cancer study
Pharmaceutical Business Review
Saturday, September 13, 2008 - 12:41pm
tags:
Jazz Pharmaceuticals completes first Phase III study of fibromyalgia drug
Pharmaceutical Business Review
Saturday, September 13, 2008 - 12:40pm
tags:
Tianyin Pharmaceutical wins Chinese approval for asthma drug
Pharmaceutical Business Review
Saturday, September 13, 2008 - 12:39pm
tags:
BioLink shifts strategy to making drugs
San Antonio Business Journal, TX
Saturday, September 13, 2008 - 12:38pm
tags:
Angiotech Announces Extension of the Expiration Date of its Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014
CNW Telbec
Saturday, September 13, 2008 - 12:36pm
tags:
J&J's pharma chief leaving in'09
Star-Ledger, NJ
Saturday, September 13, 2008 - 12:36pm
tags:
Biopharmaceutical firm Catalyst Pharmaceutical to sell shares
Miami Herald, FL
Saturday, September 13, 2008 - 12:32pm
tags:
Patent for Stem Cell Breakthrough Awarded to Japanese University
MedIndia
Saturday, September 13, 2008 - 12:28pm
tags:
Vaccine against HER2-positive breast cancer offers complete protection in lab
WKYC-TV, OH
Saturday, September 13, 2008 - 12:26pm
tags:
Health Winners & Losers: Gilead
Yahoo/TheStreet.com
Friday, September 12, 2008 - 6:49pm
tags:
FDA clears Merck's Gardasil against 2 new cancers
Yahoo/AP
Friday, September 12, 2008 - 6:47pm
tags:
A New Wrinkle for an Old Drug
Motley Fool
Friday, September 12, 2008 - 6:42pm
tags:
Abbott Laboratories sets quarterly dividend
Yahoo/AP
Friday, September 12, 2008 - 6:41pm
tags:
King's Unstoppable Urge to Merge
Motley Fool
Friday, September 12, 2008 - 3:25pm
tags:
Investors await crucial bone drug data from Amgen
Reuters
Friday, September 12, 2008 - 3:23pm
tags:
Firm: Cancer drug market could hit $90 billion by 2013 on blockbuster growth, pipeline drugs
Yahoo/AP
Friday, September 12, 2008 - 3:22pm
tags:
Glaxo Rejiggers Cancer Research
WSJ Online
Friday, September 12, 2008 - 3:22pm
tags:
King Pharmaceuticals launches hostile Alpharma bid
Yahoo/AP
Friday, September 12, 2008 - 10:54am
tags:

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility
Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

FDA Approves Fasenra for Eosinophilic Granulomatosis with Polyangiitis
pharmexec
FDA Approves Keytruda Plus Pemetrexed, Platinum Chemotherapy for Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma
pharmexec
Keytruda Demonstrates Superior Overall Survival vs. Yervoy in Advanced Melanoma
pharmexec
CAR-T For Autoimmune Disorders
In the Pipeline
A Better Response to Inflammation: Q&A with Dr. Ira Spector
pharmexec
Braftovi Plus Mektovi Demonstrates Sustained Efficiency in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer
pharmexec
GSK Launches Brooke Shields’ Led Campaign Promoting Shingles Vaccine
pharmexec
Pharma Pulse: 9/18/24: How Drug Shortages Affect Pharmacovigilance, Long Strange Trip Continues for Psychedelics & more
pharmexec
Pharmaceutical Executive: September 2024 Issue (PDF)
pharmexec

Latest Jobs

Account Manager-Los Angeles-Ophthalmics
Los Angeles, California, 90079
Sun Pharmaceutical Industries, Inc.
Regional Sales Manager - Eyecare - East Region
Miami, Florida, 33222
PV8 US Innovex Inc.
Business Development Manager- Tampa, Florida
Tampa, Florida, 33646
Hanger Clinic
Neuroscience Account Manager (Psychiatry) - Burbank, CA
Burbank, California, 91520
Vanda Pharmaceuticals
Territory Account Associate- Grand Rapids, MI
Grand Rapids, Michigan, 49528
Amplity Health
Surgical Solutions Field Sales Associate - Remote
Milwaukee, Wisconsin, 53244
W.L. Gore & Associates
Manager, Business Development - Physician Relations - Days - Full-Time
Baton Rouge, Louisiana, 70873
Woman's Hospital
Area Business Manager - Pulmonology - Greenville, SC
Asheville, North Carolina, 28814
Sanofi
Area Manager, Specialty Atlantic Region
Fields, Oregon, 97710
CSL Behring
Territory Manager (PCP) (Madison, AL)
Huntsville, Alabama, 35824
Bausch Health
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information